In June, 2009, an article in the Boston Globe described how the Boston area based biotechnology company Genzyme sold some astonishlingly expensive drugs, using
gaucher patientsGenzyme's "Remarkable Business'Strategy" and Contaminated DrugsHealth Care Renewal Wed, 11/18/2009 - 15:42
|
